UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
regorafenib (596) 596
science & technology (410) 410
life sciences & biomedicine (404) 404
oncology (275) 275
humans (231) 231
colorectal cancer (194) 194
metastasis (108) 108
phenylurea compounds - therapeutic use (107) 107
sorafenib (106) 106
hepatocellular carcinoma (103) 103
pyridines - therapeutic use (102) 102
colorectal neoplasms - drug therapy (97) 97
male (92) 92
pharmacology & pharmacy (91) 91
antineoplastic agents - therapeutic use (88) 88
female (87) 87
chemotherapy (86) 86
cancer (84) 84
tumors (79) 79
metastatic colorectal cancer (78) 78
middle aged (75) 75
patients (72) 72
phenylurea compounds - adverse effects (70) 70
pyridines - adverse effects (69) 69
phenylurea compounds - administration & dosage (67) 67
pyridines - administration & dosage (67) 67
drug therapy (66) 66
phenylurea compounds - pharmacology (66) 66
pyridines - pharmacology (66) 66
cancer therapies (64) 64
aged (63) 63
treatment outcome (61) 61
animals (59) 59
colorectal neoplasms - pathology (58) 58
angiogenesis (57) 57
care and treatment (56) 56
liver cancer (54) 54
antineoplastic agents - adverse effects (53) 53
antineoplastic agents - pharmacology (52) 52
medicine & public health (52) 52
analysis (49) 49
digestive system diseases (48) 48
adult (47) 47
bevacizumab (46) 46
protein kinase inhibitors - therapeutic use (44) 44
sunitinib (41) 41
neoplasm metastasis (40) 40
survival (40) 40
clinical trials (39) 39
review (38) 38
antineoplastic agents (37) 37
kinases (37) 37
liver neoplasms - drug therapy (37) 37
aflibercept (36) 36
antineoplastic combined chemotherapy protocols - therapeutic use (36) 36
metastases (35) 35
neoplasms. tumors. oncology. including cancer and carcinogens (35) 35
antineoplastic agents - administration & dosage (34) 34
imatinib (34) 34
mutation (34) 34
vascular endothelial growth factor (34) 34
ramucirumab (33) 33
carcinoma, hepatocellular - drug therapy (32) 32
gastroenterology & hepatology (32) 32
gist (32) 32
lenvatinib (32) 32
research (32) 32
tyrosine (32) 32
apoptosis (31) 31
cell line, tumor (31) 31
colorectal carcinoma (31) 31
antimitotic agents (30) 30
protein kinase inhibitors - pharmacology (30) 30
cabozantinib (29) 29
medical prognosis (29) 29
molecular targeted therapy (29) 29
neoplasms (29) 29
case report (27) 27
health aspects (27) 27
physical sciences (27) 27
cell biology (26) 26
cetuximab (26) 26
drug dosages (26) 26
growth factors (26) 26
hypertension (26) 26
panitumumab (26) 26
prognosis (26) 26
protein kinase inhibitors - adverse effects (26) 26
tas-102 (26) 26
toxicity (26) 26
chemistry (25) 25
development and progression (25) 25
gastrointestinal stromal tumor (25) 25
medical research (25) 25
phenylurea compounds - pharmacokinetics (25) 25
pyridines - pharmacokinetics (25) 25
biochemistry & molecular biology (24) 24
hepatoma (24) 24
mice (24) 24
niacinamide - analogs & derivatives (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (583) 583
Russian (16) 16
Japanese (7) 7
French (6) 6
Korean (5) 5
Spanish (4) 4
Chinese (3) 3
Czech (2) 2
German (1) 1
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and molecular hepatology, ISSN 2287-2728, 07/2020, Volume 26, Issue 3, p. 328
Journal Article
Oncotarget, ISSN 1949-2553, 10/2019, Volume 10, Issue 59, pp. 6286 - 6287
Journal Article
Gut, ISSN 0017-5749, 08/2018, Volume 67, Issue 8, pp. 1484 - 1492
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2013, Volume 49, Issue 16, pp. 3412 - 3419
Hematology, Oncology and Palliative Medicine | Second line | Regorafenib | Hepatocellular carcinoma | Tolerability | Safety | Receptor kinase inhibition | Safety Second line | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Pharmacology. Drug treatments | Tumors | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - mortality | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacokinetics | Phenylurea Compounds - pharmacokinetics | Liver Neoplasms - enzymology | Pyridines - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Pyridines - administration & dosage | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Treatment Outcome | Carcinoma, Hepatocellular - enzymology | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging | Care and treatment | Safety and security measures | Hepatoma | Index Medicus
Journal Article
Cancer treatment and research communications, ISSN 2468-2942, 2021, Volume 26, pp. 100263 - 100263
Journal Article
Oncotarget, ISSN 1949-2553, 06/2019, Volume 10, Issue 40, pp. 3998 - 3999
Journal Article
Current oncology (Toronto), ISSN 1198-0052, 12/2020, Volume 27, Issue 6, pp. 300 - 306
Journal Article